Deelnemende ziekenhuizen

In voorbereiding

  • Rijnstate (W. Deenik)

Officiƫle titel

Tislelizumab plus gemcitabine and cisplatin for relapsed or refractory Hodgkin lymphoma followed by tislelizumab consolidation in patients in metabolic complete response (TIGERR-HL)

Studiedocumenten

VOLGT